Your browser doesn't support javascript.
loading
Work productivity in rhinitis using cell phones: The MASK pilot study.
Bousquet, J; Bewick, M; Arnavielhe, S; Mathieu-Dupas, E; Murray, R; Bedbrook, A; Caimmi, D P; Vandenplas, O; Hellings, P W; Bachert, C; Anto, J M; Bergmann, K C; Bindslev-Jensen, C; Bosnic-Anticevich, S; Bouchard, J; Canonica, G W; Chavannes, N H; Cruz, A A; Dahl, R; Demoly, P; De Vries, G; Devillier, P; Fink-Wagner, A; Fokkens, W J; Fonseca, J; Guldemond, N A; Haahtela, T; Hellqvist-Dahl, B; Just, J; Keil, T; Klimek, L; Kowalski, M L; Kuna, P; Kvedariene, V; Laune, D; Larenas-Linnemann, D; Mullol, J; Pereira, A M; Carreiro-Martins, P; Melén, E; Morais-Almeida, M; Nogueira-Silva, L; O'Hehir, R E; Papadopoulos, N G; Passalacqua, G; Portejoie, F; Price, D; Ryan, D; Samolinski, B; Sheikh, A.
Afiliação
  • Bousquet J; MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
  • Bewick M; INSERM U 1168, VIMA: Ageing and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France.
  • Arnavielhe S; Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France.
  • Mathieu-Dupas E; iQ4U Consultants Ltd, London, UK.
  • Murray R; Kyomed, Montpellier, France.
  • Bedbrook A; Kyomed, Montpellier, France.
  • Caimmi DP; Medical Communications Consultant, MedScript Ltd, Dundalk, Co. Louth, Ireland.
  • Vandenplas O; MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
  • Hellings PW; Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, Paris, France.
  • Bachert C; Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
  • Anto JM; Department of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.
  • Bergmann KC; Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Bindslev-Jensen C; Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
  • Bosnic-Anticevich S; ISGLoBAL, Centre for Research in Environmental Epidemiology (CREAL), IMIM (Hospital del Mar Research Institute), CIBER Epidemiología y Salud Pública (CIBERESP) & Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Bouchard J; Global Allergy and Asthma European Network (GA2LEN), Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Canonica GW; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
  • Chavannes NH; Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW, Australia.
  • Cruz AA; Laval's Unit, Clinical Medicine, Quebec City, QC, Canada.
  • Dahl R; Hôpital de La Malbaie, La Malbaie, QC, Canada.
  • Demoly P; Personalized Medicine Clinic Asthma & Allergy, Humanitas University, Humanitas Research Hospital, Rozzano, Milano, Italy.
  • De Vries G; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
  • Devillier P; ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil.
  • Fink-Wagner A; GARD Executive Committee, Bahia, Brazil.
  • Fokkens WJ; ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil.
  • Fonseca J; GARD Executive Committee, Bahia, Brazil.
  • Guldemond NA; Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
  • Haahtela T; Peercode DV, Gerdermalsen, The Netherlands.
  • Hellqvist-Dahl B; Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Suresnes, France.
  • Just J; Global Allergy and Asthma Platform GAAPP, Vienna, Austria.
  • Keil T; Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
  • Klimek L; Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
  • Kowalski ML; Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal.
  • Kuna P; Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, The Netherlands.
  • Kvedariene V; Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
  • Laune D; Department of Respiratory Diseases, Odense University Hospital, Odense, Denmark.
  • Larenas-Linnemann D; Allergology Department, Centre de l'Asthme et des Allergies. Hôpital d'Enfants Armand-Trousseau (APHP), Paris, France.
  • Mullol J; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Paris, France.
  • Pereira AM; Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Carreiro-Martins P; Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
  • Melén E; Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Morais-Almeida M; Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, Lodz, Poland.
  • Nogueira-Silva L; HARC, Lodz, Poland.
  • O'Hehir RE; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
  • Papadopoulos NG; Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
  • Passalacqua G; Kyomed, Montpellier, France.
  • Portejoie F; Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, México City, Mexico.
  • Price D; Clinical & Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Ryan D; Immunoallergy Department, CUF-Descobertas Hospital, Lisbon, Portugal.
  • Samolinski B; Health Information and Decision Sciences Department, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Sheikh A; Allergy Unit, CUF-Porto Hospital & Institute, Porto, Portugal.
Allergy ; 72(10): 1475-1484, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28387952
ABSTRACT
Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAIAS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P<0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAIAS (Rho=0.53, P<0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rinite / Telefone Celular / Eficiência / Desempenho Profissional Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rinite / Telefone Celular / Eficiência / Desempenho Profissional Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França